About NextCode Health
NextCode Health is a Healthcare company based in Cambridge (United States) founded in 2013, and was acquired by WuXi AppTec in January 2015. Genomics platform for clinical insights and rapid diagnoses is provided. NextCode Health has raised $15 million across 1 funding round from investors including WuXi AppTec, Arch Venture Partners and Polaris Partners. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is NextCODE Health LLC. Its competitors include Foundation Medicine, Personalis and Veritas Genetics; 3 of its 3 listed competitors have raised funding.
Company details
NextCode Health was founded in 2013 and is located in Cambridge, United States. Operations are focused on sequence-based clinical diagnostics within the genomics sector. A platform is offered to enable physicians in obtaining clinical insights for rapid patient diagnoses. Services including data analysis, genome interpretation, and data mining are provided. Since January 2015, the company has been operated as a subsidiary of WuXi PharmaTech (Cayman).
- Headquarters Cambridge, United States
- Stage Acquired
- SectorsHealthcare
- Website nextcode.com
- Social LinkedIn Facebook
- Acquired by WuXi AppTec (Jan 2015)
- Legal Name Nextcode Health Llc
- Total Equity Funding$15M (USD)
in 1 rounds
- Latest Funding Round$15M (USD), Series A
Oct 2013
- InvestorsWuXi AppTec
& 2 more
- Acquired byWuXi AppTec
(Jan 2015)
Funding Insights of NextCode Health
NextCode Health has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series A round of $15 million completed in October 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15M
- Total Rounds 1
- Last Round Series A — $15M
- First Round $15M
(Oct 2013)
- Investors Count 2
All 1 funding rounds of NextCode Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2013 | $15M | Series A | – | – |
3 investors in total: 3 institutional.
Investors in NextCode Health
NextCode Health has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include WuXi AppTec, Arch Venture Partners and Polaris Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US focused venture capital firm | polarispartners.com | Boston, United States | ||
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
Provider of CRO and CDMO services | 2000 | wuxiapptec.com | Shanghai, China |
Investor details for NextCode Health
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of NextCode Health
3 dated milestones of NextCode Health across 2 years, from founding to its latest funding, stage changes and deals.
- Founded NextCode Health is founded.
- Funding First funding round of $15.0M.
- Exit Acquired by WuXi AppTec.
Competitors of NextCode Health
NextCode Health has 3 listed competitors in our database, 3 of them funded. They include Foundation Medicine, Personalis and Veritas Genetics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| personalis.com | 2011 | Menlo Park, United States | $87.3M | 310 | Genomic sequencing and diagnosis software is provided for healthcare. | |
| veritasgenetics.com | 2014 | Danvers, United States | $53.38M | 14 | Genetic testing products for health risks and traits are offered. |
Detailed competitors of NextCode Health
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as NextCode Health (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NextCode Health
NextCode Health was founded in 2013.
NextCode Health is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
NextCode Health is a funded company, having raised a total of $15M across 1 funding round to date. The company's 1st funding round was a Series A of $15M, raised on Oct 2013.
NextCode Health was founded in 2013 and is located in Cambridge, United States. Operations are focused on sequence-based clinical diagnostics within the genomics sector. A platform is offered to enable physicians in obtaining clinical insights for rapid patient diagnoses. Services including data analysis, genome interpretation, and data mining are provided. Since January 2015, the company has been operated as a subsidiary of WuXi PharmaTech (Cayman).
NextCode Health's top competitors include Foundation Medicine, Personalis and Veritas Genetics.
NextCode Health has 3 investors. Key investors include WuXi AppTec, Arch Venture Partners, and Polaris Partners.
NextCode Health operates through Nextcode Health Llc.
Yes. NextCode Health was acquired by WuXi AppTec in January 2015.